<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK11168" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK11168/" /><meta name="ncbi_pagename" content="Geleophysic Dysplasia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Geleophysic Dysplasia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Geleophysic Dysplasia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/10/11" /><meta name="citation_author" content="Pauline Marzin" /><meta name="citation_author" content="Valérie Cormier-Daire" /><meta name="citation_pmid" content="20301776" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK11168/" /><meta name="citation_keywords" content="ADAMTS-like protein 2" /><meta name="citation_keywords" content="Fibrillin-1" /><meta name="citation_keywords" content="Latent-transforming growth factor beta-binding protein 3" /><meta name="citation_keywords" content="ADAMTSL2" /><meta name="citation_keywords" content="FBN1" /><meta name="citation_keywords" content="LTBP3" /><meta name="citation_keywords" content="Geleophysic Dysplasia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Geleophysic Dysplasia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Pauline Marzin" /><meta name="DC.Contributor" content="Valérie Cormier-Daire" /><meta name="DC.Date" content="2018/10/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK11168/" /><meta name="description" content="Geleophysic dysplasia, a progressive condition resembling a lysosomal storage disorder, is characterized by short stature, short hands and feet, progressive joint limitation and contractures, distinctive facial features, progressive cardiac valvular disease, and thickened skin. Intellect is normal. Major findings are likely to be present in the first year of life. Cardiac, respiratory, and lung involvement result in death before age five years in approximately 33% of individuals with ADAMTSL2-related geleophysic dysplasia." /><meta name="og:title" content="Geleophysic Dysplasia" /><meta name="og:type" content="book" /><meta name="og:description" content="Geleophysic dysplasia, a progressive condition resembling a lysosomal storage disorder, is characterized by short stature, short hands and feet, progressive joint limitation and contractures, distinctive facial features, progressive cardiac valvular disease, and thickened skin. Intellect is normal. Major findings are likely to be present in the first year of life. Cardiac, respiratory, and lung involvement result in death before age five years in approximately 33% of individuals with ADAMTSL2-related geleophysic dysplasia." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK11168/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/geleophys-dysp/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK11168/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89A1F1E04026810000000005D60269.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK11168_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK11168_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gaucher/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gaci/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK11168_"><span class="title" itemprop="name">Geleophysic Dysplasia</span></h1><p class="contrib-group"><span itemprop="author">Pauline Marzin</span>, MD and <span itemprop="author">Val&#x000e9;rie Cormier-Daire</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK11168_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK11168_ai__"><div class="contrib half_rhythm"><span itemprop="author">Pauline Marzin</span>, MD<div class="affiliation small">Department of Medical Genetics<br />INSERM U1163<br />Paris-Descartes University<br />Imagine Institute<br />AP-HP, Necker-Enfants Malades Hospital<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@zram.eniluap" class="oemail">moc.liamg@zram.eniluap</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Val&#x000e9;rie Cormier-Daire</span>, MD, PhD<div class="affiliation small">Department of Medical Genetics<br />INSERM U1163<br />Paris-Descartes University<br />Imagine Institute<br />AP-HP, Necker-Enfants Malades Hospital<br />Paris, France<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="rf.mresni@eriad-reimroc.eirelav" class="oemail">rf.mresni@eriad-reimroc.eirelav</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 22, 2009</span>; Last Update: <span itemprop="dateModified">October 11, 2018</span>.</p><p><em>Estimated reading time: 20 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="geleophys-dysp.Summary" itemprop="description"><h2 id="_geleophys-dysp_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Geleophysic dysplasia, a progressive condition resembling a lysosomal storage disorder, is characterized by short stature, short hands and feet, progressive joint limitation and contractures, distinctive facial features, progressive cardiac valvular disease, and thickened skin. Intellect is normal. Major findings are likely to be present in the first year of life. Cardiac, respiratory, and lung involvement result in death before age five years in approximately 33% of individuals with <i>ADAMTSL2-</i>related geleophysic dysplasia.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The clinical diagnosis of geleophysic dysplasia is based on clinical and radiographic findings. The molecular diagnosis is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> who also has one of the following on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>: <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ADAMTSL2</i> or a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in either <i>FBN1</i> or <i>LTBP3.</i></p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Regular physiotherapy to prevent joint limitation; cardiac valve replacement as needed; tracheostomy as required.</p><p><i>Surveillance:</i> Annual multidisciplinary examination to access height and range of motion of the joints; echocardiography for evidence of valvular stenosis and/or arterial narrowing; clinical assessment for evidence of tracheal stenosis and respiratory compromise; clinical assessment and ultrasound examination, if needed, to assess liver size.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Geleophysic dysplasia caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ADAMTSL2</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Geleophysic dysplasia caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in either <i>FBN1</i> or <i>LTBP3</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><ul><li class="half_rhythm"><div>Autosomal recessive inheritance. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Autosomal dominant inheritance. To date, all individuals diagnosed with <i>FBN1-</i> or <i>LTBP3</i>-related geleophysic dysplasia have had a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. If the <i>FBN1</i> or <i>LTBP3</i> pathogenic variant found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in a family are known, the following are possible: <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for relatives at increased risk for <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> geleophysic dysplasia, <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a>, and prenatal testing for pregnancies at increased risk for either autosomal recessive or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> geleophysic dysplasia.</p></div></div><div id="geleophys-dysp.Diagnosis"><h2 id="_geleophys-dysp_Diagnosis_">Diagnosis</h2><div id="geleophys-dysp.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Geleophysic dysplasia <b>should be suspected</b> in individuals with the following clinical and radiographic findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Proportionate short stature</div></li><li class="half_rhythm"><div>Very short hands and feet</div></li><li class="half_rhythm"><div>Progressive joint limitation and contractures</div></li><li class="half_rhythm"><div>Distinctive facial features: round, full face; small nose with anteverted nostrils; broad nasal bridge; thin upper lip with flat philtrum [<a class="bk_pop" href="#geleophys-dysp.REF.allali.2011.417">Allali et al 2011</a>]</div></li><li class="half_rhythm"><div>Thickened skin</div></li><li class="half_rhythm"><div>Progressive cardiac valvular disease diagnosed on echocardiography</div></li><li class="half_rhythm"><div>Normal intellect</div></li><li class="half_rhythm"><div>Additional features:</div><ul><li class="half_rhythm"><div>Hepatomegaly</div></li><li class="half_rhythm"><div>Tracheal stenosis</div></li><li class="half_rhythm"><div>Recurrent respiratory and middle-ear infections</div></li></ul></li></ul><p><b>Radiographic findings</b></p><ul><li class="half_rhythm"><div>Delayed bone age</div></li><li class="half_rhythm"><div>Broad proximal phalanges</div></li><li class="half_rhythm"><div>Cone-shaped phalangeal epiphyses</div></li><li class="half_rhythm"><div>Shortened long tubular bones</div></li><li class="half_rhythm"><div>Small capital femoral epiphyses</div></li></ul></div><div id="geleophys-dysp.Establishing_the_Diagnosi"><h3>Establishing the Diagnosis</h3><p>The clinical diagnosis of geleophysic dysplasia is based on clinical and radiographic findings (see <a href="#geleophys-dysp.Suggestive_Findings">Suggestive Findings</a>).</p><p>The molecular diagnosis of geleophysic dysplasia <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical and radiographic findings and one of the following on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (<a class="figpopup" href="/books/NBK11168/table/geleophys-dysp.T.molecular_genetic_testi/?report=objectonly" target="object" rid-figpopup="figgeleophysdyspTmoleculargenetictesti" rid-ob="figobgeleophysdyspTmoleculargenetictesti">Table 1</a>):</p><ul><li class="half_rhythm"><div>Biallelic pathogenic variants in <i>ADAMTSL2</i> (~50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [<a class="bk_pop" href="#geleophys-dysp.REF.le_goff.2009.418">Le Goff &#x00026; Cormier-Daire 2009</a>, <a class="bk_pop" href="#geleophys-dysp.REF.cheng.2018.219">Cheng et al 2018</a>]</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FBN1</i> (~50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [<a class="bk_pop" href="#geleophys-dysp.REF.le_goff.2009.418">Le Goff &#x00026; Cormier-Daire 2009</a>, <a class="bk_pop" href="#geleophys-dysp.REF.cheng.2018.219">Cheng et al 2018</a>]</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>LTBP3</i> (~&#x0003c;1% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals) [<a class="bk_pop" href="#geleophys-dysp.REF.mcinerneyleo.2016.457">McInerney-Leo et al 2016</a>]</div></li></ul><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (concurrent or serial single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Individuals with the distinctive findings described in <a href="#geleophys-dysp.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#geleophys-dysp.Option_1">Option 1</a>), whereas those in whom the diagnosis of geleophysic dysplasia has not been considered are more likely to be diagnosed using genomic testing (see <a href="#geleophys-dysp.Option_2">Option 2</a>).</p><div id="geleophys-dysp.Option_1"><h4>Option 1</h4><p>When the diagnosis of geleophysic dysplasia is considered, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include concurrent or serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected.</p><dl class="temp-labeled-list"><dt>1.</dt><dd><p class="no_top_margin">Perform <i>ADAMTSL2</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first if <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance is suspected or there is known <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a>.</p></dd><dt>2.</dt><dd><p class="no_top_margin">If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform <i>FBN1</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p></dd><dt>3.</dt><dd><p class="no_top_margin">If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform <i>LTBP3</i> <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p></dd></dl><p><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ADAMTSL2</i>, <i>FBN1</i>, <i>LTBP3</i>, and other genes of interest (see <a href="#geleophys-dysp.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="geleophys-dysp.Option_2"><h4>Option 2</h4><p>When the diagnosis of geleophysic dysplasia is not considered, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible. If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>; however, to date no (multi)exon deletions or duplications have been detected in any of the three genes.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="geleophys-dysp.T.molecular_genetic_testi" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Geleophysic Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11168/table/geleophys-dysp.T.molecular_genetic_testi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__geleophys-dysp.T.molecular_genetic_testi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of Geleophysic Dysplasia Attributed to Pathogenic Variants in This Gene</th><th id="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detectable by This Method</th></tr><tr><th headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_3" id="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_3" id="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ADAMTSL2</i></td><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~50%&#x000a0;<sup>6</sup></td><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_3 hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%</td><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_3 hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown (none reported to date)</td></tr><tr><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i></td><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~50%&#x000a0;<sup>6</sup></td><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_3 hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%</td><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_3 hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown (none reported to date)</td></tr><tr><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LTBP3</i></td><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>7</sup></td><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_3 hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~99%</td><td headers="hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_1_3 hd_h_geleophys-dysp.T.molecular_genetic_testi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown (none reported to date)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="geleophys-dysp.TF.1.1"><p class="no_margin">Genes are listed in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="geleophys-dysp.TF.1.2"><p class="no_margin">See <a href="/books/NBK11168/#geleophys-dysp.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>3. </dt><dd><div id="geleophys-dysp.TF.1.3"><p class="no_margin">See <a href="#geleophys-dysp.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="geleophys-dysp.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="geleophys-dysp.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="geleophys-dysp.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#geleophys-dysp.REF.le_goff.2009.418">Le Goff &#x00026; Cormier-Daire [2009]</a>, <a class="bk_pop" href="#geleophys-dysp.REF.cheng.2018.219">Cheng et al [2018]</a></p></div></dd><dt>7. </dt><dd><div id="geleophys-dysp.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#geleophys-dysp.REF.mcinerneyleo.2016.457">McInerney-Leo et al [2016]</a></p></div></dd></dl></div></div></div></div></div></div><div id="geleophys-dysp.Clinical_Characteristics"><h2 id="_geleophys-dysp_Clinical_Characteristics_">Clinical Characteristics</h2><div id="geleophys-dysp.Clinical_Description"><h3>Clinical Description</h3><p>Geleophysic dysplasia is a progressive disorder resembling a lysosomal storage disorder, involving bones and joints, cardiac valves, and skin. To date about 80 individuals have been reported: 33 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#geleophys-dysp.REF.allali.2011.417">Allali et al 2011</a>] and 53 in case reports between 1960 and 2018 [<a class="bk_pop" href="#geleophys-dysp.REF.vanace.1960.80">Vanace et al 1960</a>, <a class="bk_pop" href="#geleophys-dysp.REF.spranger.1971.97">Spranger et al 1971</a>, <a class="bk_pop" href="#geleophys-dysp.REF.koiffmann.1984.483">Koiffmann et al 1984</a>, <a class="bk_pop" href="#geleophys-dysp.REF.spranger.1984a.487">Spranger et al 1984a</a>, <a class="bk_pop" href="#geleophys-dysp.REF.spranger.1984b.501">Spranger et al 1984b</a>, <a class="bk_pop" href="#geleophys-dysp.REF.peters.1985.225">Peters et al 1985</a>, <a class="bk_pop" href="#geleophys-dysp.REF.lipson.1987.181">Lipson et al 1987</a>, <a class="bk_pop" href="#geleophys-dysp.REF.shohat.1990.227">Shohat et al 1990</a>, <a class="bk_pop" href="#geleophys-dysp.REF.wraith.1990.153">Wraith et al 1990</a>, <a class="bk_pop" href="#geleophys-dysp.REF.lipson.1991.824">Lipson et al 1991</a>, <a class="bk_pop" href="#geleophys-dysp.REF.rosser.1995.217">Rosser et al 1995</a>, <a class="bk_pop" href="#geleophys-dysp.REF.figuera.1996.361">Figuera 1996</a>, <a class="bk_pop" href="#geleophys-dysp.REF.hennekam.1996.311">Hennekam et al 1996</a>, <a class="bk_pop" href="#geleophys-dysp.REF.pontz.1996.50">Pontz et al 1996</a>, <a class="bk_pop" href="#geleophys-dysp.REF.rennie.1997.1067">Rennie et al 1997</a>, <a class="bk_pop" href="#geleophys-dysp.REF.santolaya.1997.85">Santolaya et al 1997</a>, <a class="bk_pop" href="#geleophys-dysp.REF.titomanlio.1999.82">Titomanlio et al 1999</a>, <a class="bk_pop" href="#geleophys-dysp.REF.keret.2002.100">Keret et al 2002</a>, <a class="bk_pop" href="#geleophys-dysp.REF.matsui.2002.371">Matsui et al 2002</a>, <a class="bk_pop" href="#geleophys-dysp.REF.zhang.2004.198">Zhang et al 2004</a>, <a class="bk_pop" href="#geleophys-dysp.REF.panagopoulos.2005.818">Panagopoulos et al 2005</a>, <a class="bk_pop" href="#geleophys-dysp.REF.scott.2005.320">Scott et al 2005</a>, <a class="bk_pop" href="#geleophys-dysp.REF.giray.2008.161">Giray et al 2008</a>, <a class="bk_pop" href="#geleophys-dysp.REF.bensalem.2013.764">Ben-Salem et al 2013</a>, <a class="bk_pop" href="#geleophys-dysp.REF.lee.2013.456">Lee et al 2013</a>, <a class="bk_pop" href="#geleophys-dysp.REF.porayette.2014.209">Porayette et al 2014</a>, <a class="bk_pop" href="#geleophys-dysp.REF.elhoury.2015.81">Elhoury et al 2015</a>, <a class="bk_pop" href="#geleophys-dysp.REF.garc_aortiz.2015.1949">Garc&#x000ed;a-Ortiz et al 2015</a>, <a class="bk_pop" href="#geleophys-dysp.REF.mackenroth.2016.106">Mackenroth et al 2016</a>, <a class="bk_pop" href="#geleophys-dysp.REF.mcinerneyleo.2016.457">McInerney-Leo et al 2016</a>, <a class="bk_pop" href="#geleophys-dysp.REF.li.2017.685">Li et al 2017</a>, <a class="bk_pop" href="#geleophys-dysp.REF.cheng.2018.219">Cheng et al 2018</a>].</p><p>Major findings are likely to be present in the first year of life.</p><p>A skeletal disorder is usually suspected at birth because of short stature and short hands and feet. The final height is between -3 SD and -6 SD. The progressive joint limitation and skin thickening interfere with normal joint function, leading to toe walking, contractions at large joints, and limitation of wrist and hand movement.</p><p>Cardiac findings are likely to become evident in the first year of life: 23/33 (70%) of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children had cardiac anomalies (pulmonary stenosis, atrial septal defect) and had valvular thickening [<a class="bk_pop" href="#geleophys-dysp.REF.allali.2011.417">Allali et al 2011</a>; Authors, personal observation]; pulmonary arterial hypertension was observed in a few. The cardiac disease is progressive with dilation and thickening of the pulmonary, aortic, and mitral valves. Among those with valvular thickening, 30%-40% of affected children underwent valve replacement.</p><p>Intermittent hearing loss from otitis media is common.</p><p>Hepatomegaly, tracheal stenosis (observed in the first years of life in the more severe cases), and bronchopulmonary insufficiency with pulmonary arterial hypertension responsible for severe respiratory problems have also been observed. Note: Hepatomegaly is not associated with liver disease.</p><p>Two individuals developed glaucoma [<a class="bk_pop" href="#geleophys-dysp.REF.saricaoglu.2013.122">Saricaoglu et al 2013</a>; Author, personal data].</p><p>In the report of 33 individuals with <i>ADAMTSL2-</i>related geleophysic dysplasia, seven children (20%) died by age 3.6 years (average age 30 months) [<a class="bk_pop" href="#geleophys-dysp.REF.allali.2011.417">Allali et al 2011</a>]; a combination of cardiac, respiratory, and lung anomalies were reported.</p><p>The oldest living <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual is age 30 years. In addition to progressive cardiac valvular thickening, survivors have short stature (&#x0003c; -3 SD), progressive joint contractures (limited range of motion of fingers, toes, wrist, and elbows, and tip-toe gait), thickened skin, and recurrent respiratory and ear infections.</p><p><b>Histologic examination</b> of skin, liver, trachea, and heart shows lysosomal-like PAS-positive vacuoles, suggestive of glycoprotein and a storage disorder.</p></div><div id="geleophys-dysp.Phenotype_Correlations_by"><h3>Phenotype Correlations by Gene</h3><p>The clinical features of <i>ADAMTSL2-</i> and <i>FBN1-</i>related geleophysic dysplasia are indistinguishable.</p><p>Individuals with <i>LTPB3</i>-related geleophysic dysplasia to date have not had cardiac valvular involvement. While the absence of cardiac valvular thickening in contrast to the severity of the lung involvement may be a distinctive clinical feature for <i>LTPB3</i>-geleophysic dysplasia [<a class="bk_pop" href="#geleophys-dysp.REF.mcinerneyleo.2016.457">McInerney-Leo et al 2016</a>], confirmation awaits additional data.</p></div><div id="geleophys-dysp.GenotypePhenotype_Correla"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are known.</p></div><div id="geleophys-dysp.Prevalence"><h3>Prevalence</h3><p>Geleophysic dysplasia is rare; 80 individuals have been reported to date. The prevalence is not known.</p></div></div><div id="geleophys-dysp.Genetically_Related_Allel"><h2 id="_geleophys-dysp_Genetically_Related_Allel_">Genetically Related (Allelic) Disorders</h2><p>No other phenotypes are known to be associated with pathogenic variants in <i>ADAMTSL2</i>.</p><p>Other phenotypes associated with pathogenic variants in <i>FBN1</i> and <i>LTBP3</i> are summarized in <a class="figpopup" href="/books/NBK11168/table/geleophys-dysp.T.allelic_disorders_to_co/?report=objectonly" target="object" rid-figpopup="figgeleophysdyspTallelicdisorderstoco" rid-ob="figobgeleophysdyspTallelicdisorderstoco">Tables 2</a> and <a class="figpopup" href="/books/NBK11168/table/geleophys-dysp.T.other_allelic_disorders/?report=objectonly" target="object" rid-figpopup="figgeleophysdyspTotherallelicdisorders" rid-ob="figobgeleophysdyspTotherallelicdisorders">3</a>. Disorders included in <a class="figpopup" href="/books/NBK11168/table/geleophys-dysp.T.allelic_disorders_to_co/?report=objectonly" target="object" rid-figpopup="figgeleophysdyspTallelicdisorderstoco" rid-ob="figobgeleophysdyspTallelicdisorderstoco">Table 2</a> have overlapping phenotypic features with geleophysic dysplasia and should be considered in the differential diagnosis.</p><div id="geleophys-dysp.T.allelic_disorders_to_co" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Allelic Disorders to Consider in the Differential Diagnosis of Geleophysic Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11168/table/geleophys-dysp.T.allelic_disorders_to_co/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__geleophys-dysp.T.allelic_disorders_to_co_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene(S)</th><th id="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_2" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Clinical Features of the Disorder</th></tr><tr><th headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_4" id="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/Geleophysic Dysplasia</th><th headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_4" id="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from Geleophysic Dysplasia</th></tr></thead><tbody><tr><td headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i>&#x000a0;<sup>1</sup><br /><i>LTBP3</i>&#x000a0;<sup>2</sup></td><td headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acromicric dysplasia&#x000a0;<sup>3</sup></td><td headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_4 hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_2_1" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Short hands</div></li><li class="half_rhythm"><div>Stiff joints</div></li><li class="half_rhythm"><div>Delayed bone age</div></li><li class="half_rhythm"><div>Cone-shaped phalangeal epiphyses</div></li><li class="half_rhythm"><div>Thickened skin</div></li><li class="half_rhythm"><div>Heart disease</div></li></ul></td><td headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_4 hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Less severe outcome</div></li><li class="half_rhythm"><div>Absence of progressive cardiac valvular thickening</div></li><li class="half_rhythm"><div>Absence of distinctive facial features</div></li><li class="half_rhythm"><div>Absence of hepatomegaly</div></li><li class="half_rhythm"><div>See footnote 4</div></li></ul></td></tr><tr><td headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i>&#x000a0;<sup>5</sup></td><td headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/weill-ms/">Weill-Marchesani syndrome</a></td><td headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>5</sup></td><td headers="hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_1_4 hd_h_geleophys-dysp.T.allelic_disorders_to_co_1_1_2_2" colspan="1" rowspan="1" style="text-align:left;vertical-align:middle;">Abnormalities of the lens of the eye (typically recognized in childhood) including:
<ul><li class="half_rhythm"><div>Microspherophakia (small spherical lens)</div></li><li class="half_rhythm"><div>Myopia secondary to abnormal shape of the lens</div></li><li class="half_rhythm"><div>Ectopia lentis (abnormal position of the lens)</div></li><li class="half_rhythm"><div>Glaucoma (can lead to blindness)</div></li></ul>
Absence of hepatomegaly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a></p></div></dd><dt>1. </dt><dd><div id="geleophys-dysp.TF.2.1"><p class="no_margin">OMIM <a href="http://omim.org/entry/102370" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">102370</a></p></div></dd><dt>2. </dt><dd><div id="geleophys-dysp.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#geleophys-dysp.REF.mcinerneyleo.2016.457">McInerney-Leo et al [2016]</a></p></div></dd><dt>3. </dt><dd><div id="geleophys-dysp.TF.2.3"><p class="no_margin">Moore Federman syndrome is probably the same as acromicric dysplasia.</p></div></dd><dt>4. </dt><dd><div id="geleophys-dysp.TF.2.4"><p class="no_margin">Additional clinical findings in 22 individuals with acromicric dysplasia from 15 families include: frequent ear, tracheal, and respiratory complications; non-progressive heart disease (4/22; 2 with bicuspid aortic valve, 2 with atrial septal defect); and myopia (8/20) [Author, personal observation].</p></div></dd><dt>5. </dt><dd><div id="geleophys-dysp.TF.2.5"><p class="no_margin"><a href="/books/n/gene/weill-ms/">Weill-Marchesani syndrome</a> is more typically caused by pathogenic variants in <i>ADAMTS10</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. A review of 128 individuals with Weill-Marchesani syndrome did not identify any clinical distinction between the two genetic etiologies, supporting the clinical homogeneity of the disorder [<a class="bk_pop" href="#geleophys-dysp.REF.faivre.2003.34">Faivre et al 2003</a>, <a class="bk_pop" href="#geleophys-dysp.REF.dagoneau.2004.801">Dagoneau et al 2004</a>]. Weill-Marchesani syndrome has also been associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>LTBP2</i>.</p></div></dd></dl></div></div></div><div id="geleophys-dysp.T.other_allelic_disorders" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Other Allelic Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11168/table/geleophys-dysp.T.other_allelic_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__geleophys-dysp.T.other_allelic_disorders_lrgtbl__"><table><thead><tr><th id="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th></tr></thead><tbody><tr><td headers="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_1" rowspan="5" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i></td><td headers="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/marfan/">Marfan syndrome</a></td></tr><tr><td headers="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Isolated ectopia lentis (OMIM <a href="https://omim.org/entry/129600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">129600</a>)</td></tr><tr><td headers="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">MASS syndrome (OMIM <a href="https://omim.org/entry/604308" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604308</a>)</td></tr><tr><td headers="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/taa/">Thoracic aortic aneurysms and aortic dissections</a></td></tr><tr><td headers="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Stiff skin syndrome (OMIM <a href="http://www.omim.org/entry/184900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">184900</a>)</td></tr><tr><td headers="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LTBP3</i></td><td headers="hd_h_geleophys-dysp.T.other_allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oligodontia [<a class="bk_pop" href="#geleophys-dysp.REF.noor.2009.519">Noor et al 2009</a>]</td></tr></tbody></table></div></div></div><div id="geleophys-dysp.Differential_Diagnosis"><h2 id="_geleophys-dysp_Differential_Diagnosis_">Differential Diagnosis</h2><p>The acromelic dysplasia group includes four rare disorders: geleophysic dysplasia, Weill-Marchesani syndrome, acromicric dysplasia, and Myhre syndrome. The clinical overlap between the four disorders is striking. Overlapping and distinguishing clinical features are summarized in <a class="figpopup" href="/books/NBK11168/table/geleophys-dysp.T.disorders_to_consider_i/?report=objectonly" target="object" rid-figpopup="figgeleophysdyspTdisorderstoconsideri" rid-ob="figobgeleophysdyspTdisorderstoconsideri">Table 4</a>. Hepatomegaly and early mortality are encountered only in the most severe forms of geleophysic dysplasia.</p><div id="geleophys-dysp.T.disorders_to_consider_i" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of Geleophysic Dysplasia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11168/table/geleophys-dysp.T.disorders_to_consider_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__geleophys-dysp.T.disorders_to_consider_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of the Disorder</th></tr><tr><th headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_4" id="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/Geleophysic Dysplasia</th><th headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_4" id="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from Geleophysic Dysplasia</th></tr></thead><tbody><tr><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acromicric dysplasia</td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i><br /><i>LTBP3</i></td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_4 hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_2_1" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">See <a class="figpopup" href="/books/NBK11168/table/geleophys-dysp.T.allelic_disorders_to_co/?report=objectonly" target="object" rid-figpopup="figgeleophysdyspTallelicdisorderstoco" rid-ob="figobgeleophysdyspTallelicdisorderstoco">Table 2</a></td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_4 hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_2_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">See <a class="figpopup" href="/books/NBK11168/table/geleophys-dysp.T.allelic_disorders_to_co/?report=objectonly" target="object" rid-figpopup="figgeleophysdyspTallelicdisorderstoco" rid-ob="figobgeleophysdyspTallelicdisorderstoco">Table 2</a></td></tr><tr><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/weill-ms/">Weill-Marchesani syndrome</a></td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i></td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;"><i>ADAMTS10</i><br /><i>ADAMTS17</i><br /><i>LTBP2</i></td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td></tr><tr><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/myhre/">Myhre syndrome</a></td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMAD4</i></td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>1</sup></td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_4 hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>IUGR</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Short hands &#x00026; feet</div></li><li class="half_rhythm"><div>Progressive joint limitation &#x00026; contractures</div></li><li class="half_rhythm"><div>Thickened skin</div></li><li class="half_rhythm"><div>Heart involvement</div></li></ul></td><td headers="hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_1_4 hd_h_geleophys-dysp.T.disorders_to_consider_i_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial features w/prognathism</div></li><li class="half_rhythm"><div>Cranial skull anomalies</div></li><li class="half_rhythm"><div>Variable degree of cognitive impairment</div></li><li class="half_rhythm"><div>Deafness</div></li></ul></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a></p></div></dd><dt></dt><dd><div><p class="no_margin">IUGR = intrauterine growth restriction</p></div></dd><dt>1. </dt><dd><div id="geleophys-dysp.TF.4.1"><p class="no_margin">All probands with Myhre syndrome reported to date have had a <i>de novo SMAD4</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div></dd></dl></div></div></div></div><div id="geleophys-dysp.Management"><h2 id="_geleophys-dysp_Management_">Management</h2><div id="geleophys-dysp.Evaluations_Following_Ini"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with geleophysic dysplasia, the evaluations summarized in this section (if not performed as part of the evaluation that led to the diagnosis) are recommended:</p><ul><li class="half_rhythm"><div>Height</div></li><li class="half_rhythm"><div>Joint range of motion by an orthopedist/physiotherapist</div></li><li class="half_rhythm"><div>Echocardiography to evaluate for evidence of valvular stenosis and/or arterial narrowing</div></li><li class="half_rhythm"><div>Clinical history for evidence of tracheal stenosis and respiratory compromise</div></li><li class="half_rhythm"><div>Liver size by clinical assessment and/or ultrasound examination</div></li><li class="half_rhythm"><div>Eye examination to evaluate for evidence of glaucoma</div></li><li class="half_rhythm"><div>Hearing assessment</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="geleophys-dysp.Treatment_of_Manifestatio"><h3>Treatment of Manifestations</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div><b>Joint manifestations.</b> Regular physiotherapy to prevent joint limitation</div></li><li class="half_rhythm"><div><b>Heart.</b> Valve replacement when severe</div></li><li class="half_rhythm"><div><b>Tracheal stenosis.</b> Tracheostomy when severe</div></li></ul></div><div id="geleophys-dysp.Surveillance"><h3>Surveillance</h3><p>Annual multidisciplinary examination to assess the following:</p><ul><li class="half_rhythm"><div>Height</div></li><li class="half_rhythm"><div>Joint range of motion by an orthopedist/physiotherapist</div></li><li class="half_rhythm"><div>Heart by echocardiography for evidence of valvular stenosis and/or arterial narrowing</div></li><li class="half_rhythm"><div>Trachea for evidence of stenosis and respiratory compromise</div></li><li class="half_rhythm"><div>Liver size for evidence of hepatomegaly</div></li></ul></div><div id="geleophys-dysp.Evaluation_of_Relatives_a"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#geleophys-dysp.Related_Genetic_Counselin">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="geleophys-dysp.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnancy is unusual in women with geleophysic dysplasia. The management of a pregnant woman is complicated due to the small pelvis, cardiac anomalies, and tracheal stenosis. It is recommended that women considering a pregnancy be evaluated prior to pregnancy and followed during pregnancy in a high-risk perinatal center.</p></div><div id="geleophys-dysp.Therapies_Under_Investiga"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="geleophys-dysp.Genetic_Counseling"><h2 id="_geleophys-dysp_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="geleophys-dysp.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Geleophysic dysplasia caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ADAMTSL2</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Geleophysic dysplasia caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in either <i>FBN1</i> or <i>LTBP3</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="geleophys-dysp.Risk_to_Family_Members__A"><h3>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>ADAMTSL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with geleophysic dysplasia 1 are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ADAMTSL2</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>ADAMTSL2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Carrier (<a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a>) detection.</b> Carrier testing for at-risk relatives requires prior identification of the <i>ADAMTSL2</i> pathogenic variants in the family.</p></div><div id="geleophys-dysp.Risk_to_Family_Members__A_1"><h3>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>To date, all individuals diagnosed with <i>FBN1-</i> or <i>LTBP3</i>-related typical geleophysic dysplasia have had a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include physical examination for signs of geleophysic dysplasia (e.g., proportionate short stature, distinctive facial features) and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> if the <i>FBN1</i> or <i>LTBP3</i> pathogenic variant has been identified in the proband. Note: Decreased <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> has not been reported to date in <i>FBN1-</i> or <i>LTBP3</i>-related geleophysic dysplasia.</div></li><li class="half_rhythm"><div>If the <i>FBN1</i> or <i>LTBP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the pathogenic variant most likely occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in the proband. Another possible explanation is that the proband inherited a pathogenic variant from a parent with <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Although theoretically possible, no instances of germline mosaicism have been reported to date.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents: if the <i>FBN1</i> or <i>LTBP3</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the proband cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#geleophys-dysp.REF.rahbari.2016.126">Rahbari et al 2016</a>].</p><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> geleophysic dysplasia has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Given that all probands with <i>FBN1-</i> or <i>LTBP3</i>-related geleophysic dysplasia reported to date have the disorder as a result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to other family members is presumed to be low.</p></div><div id="geleophys-dysp.Related_Genetic_Counselin"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="geleophys-dysp.Prenatal_Testing_and_Prei"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the geleophysic dysplasia-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="geleophys-dysp.Resources"><h2 id="_geleophys-dysp_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Heart Association (AHA)</b></div><div>7272 Greenville Avenue</div><div>Dallas TX 75231</div><div><b>Phone:</b> 800-242-8721 (toll-free)</div><div><b>Email:</b> review.personal.info@heart.org</div><div><a href="http://www.heart.org/HEARTORG/Conditions/CongenitalHeartDefects/CongenitalHeartDefectsToolsResources/Web-Booklet-If-Your-Child-Has-a-Congenital-Heart-Defect_UCM_316608_Article.jsp" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Congenital Heart Defects in Children</a></div></li><li class="half_rhythm"><div><b>MAGIC Foundation</b></div><div>4200 Cantera Drive #106</div><div>Warrenville IL 60555</div><div><b>Phone:</b> 800-362-4423 (Toll-free Parent Help Line); 630-836-8200</div><div><b>Fax:</b> 630-836-8181</div><div><b>Email:</b> contactus@magicfoundation.org</div><div><a href="http://www.magicfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.magicfoundation.org</a></div></li><li class="half_rhythm"><div><b>French Reference Center for Skeletal Dysplasia</b></div><div>H&#x000f4;pital Necker-Enfant Malades</div><div><b>Phone:</b> +33 142192713</div><div><b>Fax:</b> +33 144495150</div><div><b>Email:</b> cr.moc@nck.aphp.fr</div></li><li class="half_rhythm"><div><b>International Skeletal Dysplasia Registry</b></div><div>UCLA</div><div>615 Charles E. Young Drive</div><div>South Room 410</div><div>Los Angeles CA 90095-7358</div><div><b>Phone:</b> 310-825-8998</div><div><b>Fax:</b> 310-206-5266</div><div><b>Email:</b> Salon@mednet.ucla.edu</div><div><a href="https://www.uclahealth.org/ortho/isdr" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">International Skeletal Dysplasia Registry</a></div></li></ul></div><div id="geleophys-dysp.Molecular_Genetics"><h2 id="_geleophys-dysp_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="geleophys-dysp.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Geleophysic Dysplasia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11168/table/geleophys-dysp.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__geleophys-dysp.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_geleophys-dysp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_geleophys-dysp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_geleophys-dysp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_geleophys-dysp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_geleophys-dysp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_geleophys-dysp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/9719" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ADAMTSL2</i></a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=9719" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q34<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q86TH1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADAMTS-like protein 2</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ADAMTSL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADAMTSL2 database</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ADAMTSL2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADAMTSL2</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ADAMTSL2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ADAMTSL2</a></td></tr><tr><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2200" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FBN1</i></a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P35555" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Fibrillin-1</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://lovd.nl/FBN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FBN1 @ LOVD</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FBN1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FBN1</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FBN1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FBN1</a></td></tr><tr><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4054" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>LTBP3</i></a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4054" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">11q13<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9NS15" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Latent-transforming growth factor beta-binding protein 3</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/LTBP3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LTBP3 database</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=LTBP3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LTBP3</a></td><td headers="hd_b_geleophys-dysp.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=LTBP3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">LTBP3</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="geleophys-dysp.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="geleophys-dysp.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Geleophysic Dysplasia (<a href="/omim/134797,231050,602090,612277,614185,617809" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11168/table/geleophys-dysp.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__geleophys-dysp.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/134797" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">134797</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FIBRILLIN 1; FBN1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/231050" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">231050</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GELEOPHYSIC DYSPLASIA 1; GPHYSD1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602090" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602090</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LATENT TRANSFORMING GROWTH FACTOR-BETA-BINDING PROTEIN 3; LTBP3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/612277" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">612277</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ADAMTS-LIKE PROTEIN 2; ADAMTSL2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614185" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614185</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GELEOPHYSIC DYSPLASIA 2; GPHYSD2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/617809" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">617809</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GELEOPHYSIC DYSPLASIA 3; GPHYSD3</td></tr></tbody></table></div></div><p><b><i>ADAMTSL2</i></b></p><p><b>Gene structure.</b> The 18 coding exons of <i>ADAMTSL2</i> constitute a transcript of 40.6 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK11168/#geleophys-dysp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The pathogenic variants identified to date are located throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. The majority of pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, although <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and one 30-bp <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> affecting the N glycan-rich module were described [<a class="bk_pop" href="#geleophys-dysp.REF.allali.2011.417">Allali et al 2011</a>] (see <a class="figpopup" href="/books/NBK11168/table/geleophys-dysp.T.selected_adamtsl2_patho/?report=objectonly" target="object" rid-figpopup="figgeleophysdyspTselectedadamtsl2patho" rid-ob="figobgeleophysdyspTselectedadamtsl2patho">Table 5</a>).</p><div id="geleophys-dysp.T.selected_adamtsl2_patho" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Selected <i>ADAMTSL2</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11168/table/geleophys-dysp.T.selected_adamtsl2_patho/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__geleophys-dysp.T.selected_adamtsl2_patho_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.440C&#x0003e;T&#x000a0;<sup>1</sup></td><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">p.Pro147Leu</td><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nucleotide/223718259" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001145320<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/223718260" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001138792<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.338G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">p.Arg113His</td></tr><tr><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.340G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">p.Glu114Lys</td></tr><tr><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.2431G&#x0003e;A&#x000a0;<sup>2</sup></td><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">p.Gly811Arg</td></tr><tr><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.2586G&#x0003e;&#x000a0;<sup>2</sup></td><td headers="hd_h_geleophys-dysp.T.selected_adamtsl2_patho_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">p.Trp862Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="geleophys-dysp.TF.5.1"><p class="no_margin">Reported as <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> pathogenic variants</p></div></dd><dt>2. </dt><dd><div id="geleophys-dysp.TF.5.2"><p class="no_margin">Reported as <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> state</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> ADAMTSL2 belongs to a large superfamily containing 19 ADAMTS proteases and at least five ADAMTS-like proteins. ADAMTS proteases are secreted enzymes with a conserved organization that includes a metalloprotease <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and an ancillary domain containing one or more thrombospondin type 1 repeats (TSRs). Some ADAMTS proteases participate in extracellular matrix (ECM) turnover in arthritis and others are involved in procollagen and von Willebrand factor maturation or in angiogenesis [<a class="bk_pop" href="#geleophys-dysp.REF.apte.2004.981">Apte 2004</a>].</p><p>The ADAMTS-like subfamily comprises proteins homologous to the ADAMTS ancillary domains but lacking the protease <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and hence lacking catalytic activity. ADAMTSL-1 and ADAMTSL-3 proteins are closely related secreted glycoproteins, whereas ADAMTSL-2 has a different domain structure. Indeed, <i>ADAMTSL2</i> encodes a 951-amino-acid protein composed of a signal peptide, a TSR, a cysteine-rich module, a spacer module, an N-glycan-rich module, six additional TSRs, and a PLAC module. The function of these domains is currently unknown [<a class="bk_pop" href="#geleophys-dysp.REF.koo.2007.431">Koo et al 2007</a>].</p><p>ADAMTS-like 2 is a glycoprotein lacking enzymatic activity whose function is unknown. To define the molecular pathway in which ADAMTSL2 may participate, yeast two-hybrid screening of a human muscle <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> library was performed. The human latent TGF&#x003b2;-binding protein 1 (encoded by <i>LTBP1</i>) was identified as an ADAMTSL2 partner. The interaction of LTBP-1S (the dominant and more widely distributed protein isoform) with ADAMTSL2 was verified using immunoprecipitation [<a class="bk_pop" href="#geleophys-dysp.REF.le_goff.2008.1119">Le Goff et al 2008</a>].</p><p>The LTBP1 protein plays a major role in the storage of latent TGF&#x003b2; in the ECM and regulates its availability [<a class="bk_pop" href="#geleophys-dysp.REF.isogai.2003.2750">Isogai et al 2003</a>]. Owing to the interaction of ADAMTSL2 with LTPB1, the amount of total and active TGF&#x003b2; in the culture medium of fibroblasts from individuals with geleophysic dysplasia was investigated. Using ELISA assays, a tenfold higher level of TGF&#x003b2; was found in the culture medium of fibroblasts from <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals compared to controls (p&#x0003c;0.0003). The active TGF&#x003b2; represented 85% and 92% of total TGF&#x003b2; in culture medium of individuals with geleophysic dysplasia, whereas active TGF&#x003b2; represented only 7% of total TGF&#x003b2; in control medium [<a class="bk_pop" href="#geleophys-dysp.REF.le_goff.2008.1119">Le Goff et al 2008</a>].</p><p>The finding of a potential interaction between LTPB1 and ADAMTSL2 suggests that ADAMTSL2 may be involved in the microfibrillar network and in TGF&#x003b2; bioavailability. TGF&#x003b2; is a growth factor that regulates cell proliferation, migration, differentiation, and survival in a context-dependent fashion; its activity is tightly regulated through the ECM [<a class="bk_pop" href="#geleophys-dysp.REF.isogai.2003.2750">Isogai et al 2003</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The functional consequences of the <i>ADAMTSL2</i> pathogenic variants were tested using a myc-tagged wild type and an <i>ADAMTSL2</i> mutated construct (p.Arg113His, p.Pro147Leu, and p.Gly811Arg) in parallel transfections of HEK293F cells. Western blot analyses after 48 hours of transfection confirmed that wild type ADAMTSL2 protein was secreted into the medium. All three mutated proteins were also secreted, but at reduced levels compared to wild type ADAMTSL2. Although there was no statistically significant alteration of cellular levels, a significantly decreased secretion of each mutated protein was found. Thus, the mutated proteins are likely to be synthesized, but it is possible that they are misfolded, which may interfere with their efficient secretion. An increased turnover of mutated protein or altered function of secreted mutated protein could also explain these data [<a class="bk_pop" href="#geleophys-dysp.REF.le_goff.2008.1119">Le Goff et al 2008</a>].</p><p><b><i>FBN1</i></b></p><p><b>Gene structure.</b>
<i>FBN1</i> is large (&#x0003e;600 kb) and the coding sequence is highly fragmented (65 exons). The <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a> is large and poorly characterized. High evolutionary conservation of <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> sequence at the 5' end of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> suggests the presence of intronic regulatory elements. Three exons at the extreme 5' end of the gene are alternatively utilized and do not appear to contribute to the coding sequence (see <a href="/books/n/gene/taa/">Thoracic Aortic Aneurysms and Aortic Dissections</a>). For a detailed summary of gene and protein information, see <a href="/books/NBK11168/#geleophys-dysp.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> All <i>FBN1</i> pathogenic variants identified to date in geleophysic dysplasia are clustered in the same region (<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 41-42) encoding the TGF&#x003b2;-binding protein-like 5 (TB5) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of FBN1. Among the 16 <i>FBN1</i> pathogenic variants identified, seven were specifically identified in geleophysic dysplasia (GD), seven were specifically identified in acromicric dysplasia (AD), and two were found in individuals with either GD or AD [<a class="bk_pop" href="#geleophys-dysp.REF.le_goff.2011.7">Le Goff et al 2011</a>]. All pathogenic variants were located in exons 41-42 encoding the TB5 domain and altered either large aromatic components or structurally important residues. Half of the pathogenic variants created or removed a cysteine residue within this domain, which is characterized (as are the other TB domains) by eight cysteines directly involved in FBN1 folding via intradomain disulfide linkage.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Fibrillins are large glycoproteins (350 kd) ubiquitously expressed. They give rise to filamentous assemblies (microfibrils) with an average diameter of 10 nm. They are grouped together with LTBPs and fibulins into a structurally related family of extracellular matrix proteins. Fibrillins have a specific modular structure that consists of 46/47 epidermal growth factor (EGF)-like domains (42/43 of which are of the calcium-binding type) interspersed with seven 8-cysteine-containing modules (TB/8-Cys). The modules with 8-Cys are specific to fibrillins and LTBPs. This molecule also contains a specific binding sequence to integrin receptors &#x003b1;5&#x003b2;1, &#x003b1;v&#x003b2;3, and v&#x003b2;6. Fibrillin assemblies thus constitute the non-collagenous architectural elements of soft- and hard-tissue matrices. The importance of fibrillin deposition for the proper storage, distribution, release, and activation of locally produced TGF&#x003b2; and BMP molecules has been demonstrated.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> To analyze the consequences of <i>FBN1</i> pathogenic variants, the microfibrillar structure in skin fibroblasts of individuals with GD/AD and controls was observed by indirect immunofluorescence. Staining revealed abundant long microfibrils in controls, but fibroblasts from individuals with AD/GD demonstrated a reduced number of microfibrils and complete network disorganization.</p><p>To test the effect of TB5 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> pathogenic variants on TGF&#x003b2; signaling, the phospho-SMAD2/3 level in cell lysate of skin fibroblasts of individuals with GD/AD and age- and passage-matched controls was analyzed by Western blot; an enhanced signal was found. Consistent with this observation, the quantification of active and total TGF&#x003b2; in the cultured medium of skin fibroblasts of individuals with GD/AD by ELISA shows a tenfold higher level of total TGF&#x003b2; in the cultured medium compared to controls.</p><p>Because <i>ADAMTSL2</i> pathogenic variants were previously identified in a subset of individuals with GD, a direct link between <i>FBN1</i> associated with AD and (some cases of) GD and <i>ADAMTSL2</i> was hypothesized. To demonstrate this interaction, a surface plasmon resonance analysis using FBN1 recombinant protein was performed. A specific interaction between FBN1 and ADAMTSL2 may provide evidence that dysregulation of the FBN1/ADAMTSL2/TGF&#x003b2; interrelationship is the underlying mechanism of the short stature phenotypes.</p><p><b><i>LTBP3</i></b></p><p><b>Gene structure.</b>
<i>LTBP3</i> comprises 28 exons; the longest transcript variant is <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001130144.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><b>NM_001130144.2</b></a>. See <a href="/books/NBK11168/#geleophys-dysp.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Three pathogenic variants have been identified: a <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant, a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant located in an EGF-like calcium-binding <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> and associated with acromicric dysplasia, and a nonstop (or stop-loss) change with loss of the normal stop codon with translation likely extending into the 3'UTR [<a class="bk_pop" href="#geleophys-dysp.REF.mcinerneyleo.2016.457">McInerney-Leo et al 2016</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001130144.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><b>NM_001130144.2</b></a> encodes the 1,303-amino-acid protein <a href="https://www.ncbi.nlm.nih.gov/protein/NP_001123616.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><b>NP_001123616.1</b></a>. LTBP3 belongs to TGB&#x003b2;-binding protein (LTBP) family, comprising four proteins found in microfibrils of the ECM and structurally similar to fibrillins. It is incorporated into the ECM through its interaction with fibrillin-1 [<a class="bk_pop" href="#geleophys-dysp.REF.zilberberg.2012.3828">Zilberberg et al 2012</a>]. It contains 13 epidermal growth factor-like repeats and four TGF&#x003b2;-binding (TB) domains (or 8-cysteine domains), which are specific to the LTBP-fibrillin superfamily. LTBP3 is involved in TGF&#x003b2; secretion, trapping, and activation [<a class="bk_pop" href="#geleophys-dysp.REF.koli.2008.679">Koli et al 2008</a>]. TGF&#x003b2; signaling is important in chondrogenesis and osteogenesis [<a class="bk_pop" href="#geleophys-dysp.REF.le_goff.2015.642">Le Goff &#x00026; Cormier-Daire 2015</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The mechanism of pathogenicity for LTBP3 has not yet been fully elucidated. Pathogenic variants associated with geleophysic dysplasia are responsible for a disorganized microfibrillar network. However, TGF&#x003b2; signaling is not increased [<a class="bk_pop" href="#geleophys-dysp.REF.mcinerneyleo.2016.457">McInerney-Leo et al 2016</a>].</p></div><div id="geleophys-dysp.References"><h2 id="_geleophys-dysp_References_">References</h2><div id="geleophys-dysp.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.allali.2011.417">Allali S, Le Goff C, Pressac-Diebold I, Pfennig G, Mahaut C, Dagoneau N, Alanay Y, Brady AF, Crow YJ, Devriendt K, Drouin-Garraud V, Flori E, Genevi&#x000e8;ve D, Hennekam RC, Hurst J, Krakow D, Le Merrer M, Lichtenbelt KD, Lynch SA, Lyonnet S, MacDermot K, Mansour S, Megarban&#x000e9; A, Santos HG, Splitt M, Superti-Furga A, Unger S, Williams D, Munnich A, Cormier-Daire V. Molecular screening of ADAMTSL2 gene in 33 patients reveals the genetic heterogeneity of geleophysic dysplasia. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:417–21.</span> [<a href="/pmc/articles/PMC4413937/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4413937</span></a>] [<a href="/pubmed/21415077" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21415077</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.apte.2004.981">Apte SS. A disintegrin-like and metalloprotease (reprolysin type) with thrombospondin type 1 motifs: the ADAMTS family. <span><span class="ref-journal">Int J Biochem Cell Biol. </span>2004;<span class="ref-vol">36</span>:981–5.</span> [<a href="/pubmed/15094112" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15094112</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.bensalem.2013.764">Ben-Salem S, Hertecant J, Al-Shamsi AM, Ali BR, Al-Gazali L. Novel mutations in ADAMTSL2 gene underlying geleophysic dysplasia in families from United Arab Emirates. <span><span class="ref-journal">Birth Defects Res A Clin Mol Teratol. </span>2013;<span class="ref-vol">97</span>:764–9.</span> [<a href="/pubmed/24014090" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24014090</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.cheng.2018.219">Cheng SW, Luk HM, Chu YWY, Tung YL, Kwan EY, Lo IF, Chung BH. A report of three families with FBN1-related acromelic dysplasias and review of literature for genotype-phenotype correlation in geleophysic dysplasia. <span><span class="ref-journal">Eur J Med Genet. </span>2018;<span class="ref-vol">61</span>:219–24.</span> [<a href="/pubmed/29191498" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29191498</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.dagoneau.2004.801">Dagoneau N, Benoist-Lasselin C, Huber C, Faivre L, M&#x000e9;garban&#x000e9; A, Alswaid A, Dollfus H, Alembik Y, Munnich A, Legeai-Mallet L, Cormier-Daire V. ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:801–6.</span> [<a href="/pmc/articles/PMC1182109/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182109</span></a>] [<a href="/pubmed/15368195" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15368195</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.elhoury.2015.81">Elhoury ME, Faqeih E, Almoukirish AS, Galal MO. Cardiac involvement in geleophysic dysplasia in three siblings of a Saudi family. <span><span class="ref-journal">Cardiol Young. </span>2015;<span class="ref-vol">25</span>:81–6.</span> [<a href="/pubmed/24192049" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24192049</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.faivre.2003.34">Faivre L, Gorlin RJ, Wirtz MK, Godfrey M, Dagoneau N, Samples JR, Le Merrer M, Collod-Beroud G, Boileau C, Munnich A, Cormier-Daire V. In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. <span><span class="ref-journal">J Med Genet. </span>2003;<span class="ref-vol">40</span>:34–6.</span> [<a href="/pmc/articles/PMC1735272/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735272</span></a>] [<a href="/pubmed/12525539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12525539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.figuera.1996.361">Figuera LE. Geleophysic dysplasia vs. Myhre syndrome. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">65</span>:361–2.</span> [<a href="/pubmed/8923952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8923952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.garc_aortiz.2015.1949">Garc&#x000ed;a-Ortiz L, Guti&#x000e9;rrez-Salinas J, Del Carmen Chima Gal&#x000e1;n M, Garc&#x000ed;a RL, de la Concepci&#x000f3;n A, Yerena M. Geleophysic dysplasia: a novel in-frame deletion of a tandem repeat in the ADAMTSL2 gene. <span><span class="ref-journal">Am J Med Genet A. </span>2015;<span class="ref-vol">167A</span>:1949–51.</span> [<a href="/pubmed/25850559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25850559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.giray.2008.161">Giray O, K&#x000fd;r M, Bora E, Saylam G, Ugurlu B, G&#x000fc;rel D. Clinical and morphological phenotype of geleophysic dysplasia. <span><span class="ref-journal">Ann Trop Paediatr. </span>2008;<span class="ref-vol">28</span>:161–4.</span> [<a href="/pubmed/18510828" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18510828</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.hennekam.1996.311">Hennekam RC, van Bever Y, Oorthuys JW. Acromicric dysplasia and geleophysic dysplasia: similarities and differences. <span><span class="ref-journal">Eur J Pediatr. </span>1996;<span class="ref-vol">155</span>:311–4.</span> [<a href="/pubmed/8777926" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8777926</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.isogai.2003.2750">Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, Sakai LY. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. <span><span class="ref-journal">J Biol Chem. </span>2003;<span class="ref-vol">278</span>:2750–7.</span> [<a href="/pubmed/12429738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12429738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.keret.2002.100">Keret D, Lokiec F, Hayek S, Segev E, Ezra E. Perthes-like changes in geleophysic dysplasia. <span><span class="ref-journal">J Pediatr Orthop B. </span>2002;<span class="ref-vol">11</span>:100–3.</span> [<a href="/pubmed/11943981" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11943981</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.koiffmann.1984.483">Koiffmann CP, Wajntal A, Ursich MJ, Pupo AA. Familial recurrence of geleophysic dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>1984;<span class="ref-vol">19</span>:483–6.</span> [<a href="/pubmed/6507494" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6507494</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.koli.2008.679">Koli K, Ryyn&#x000e4;nen MJ, Keski-Oja J. Latent TGF-&#x003b2; binding proteins (LTBPs)-1 and -3 coordinate proliferation and osteogenic differentiation of human mesenchymal stem cells. <span><span class="ref-journal">Bone. </span>2008;<span class="ref-vol">43</span>:679–88.</span> [<a href="/pubmed/18672106" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18672106</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.koo.2007.431">Koo BH, Le Goff C, Jungers KA, Vasanji A, O'Flaherty J, Weyman CM, Apte SS. ADAMTS-like 2 (ADAMTSL2) is a secreted glycoprotein that is widely expressed during mouse embryogenesis and is regulated during skeletal myogenesis. <span><span class="ref-journal">Matrix Biol. </span>2007;<span class="ref-vol">26</span>:431–41.</span> [<a href="/pubmed/17509843" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17509843</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.le_goff.2015.642">Le Goff C, Cormier-Daire V. Chondrodysplasias and TGF&#x003b2; signaling. <span><span class="ref-journal">Bonekey Rep. </span>2015;<span class="ref-vol">4</span>:642.</span> [<a href="/pmc/articles/PMC4357213/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4357213</span></a>] [<a href="/pubmed/25798233" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25798233</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.le_goff.2009.418">Le Goff C, Cormier-Daire V. Genetic and molecular aspects of acromelic dysplasia. <span><span class="ref-journal">Pediatr Endocrinol Rev. </span>2009;<span class="ref-vol">6</span>:418–23.</span> [<a href="/pubmed/19396027" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19396027</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.le_goff.2011.7">Le Goff C, Mahaut C, Wang LW, Allali S, Abhyankar A, Jensen S, Zylberberg L, Collod-Beroud G, Bonnet D, Alanay Y, Brady AF, Cordier MP, Devriendt K, Genevieve D, Kiper P&#x000d6;, Kitoh H, Krakow D, Lynch SA, Le Merrer M, M&#x000e9;garbane A, Mortier G, Odent S, Polak M, Rohrbach M, Sillence D, Stolte-Dijkstra I, Superti-Furga A, Rimoin DL, Topouchian V, Unger S, Zabel B, Bole-Feysot C, Nitschke P, Handford P, Casanova JL, Boileau C, Apte SS, Munnich A, Cormier-Daire V. Mutations in the TGF&#x003b2; binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias. <span><span class="ref-journal">Am J Hum Genet. </span>2011;<span class="ref-vol">89</span>:7–14.</span> [<a href="/pmc/articles/PMC3135800/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3135800</span></a>] [<a href="/pubmed/21683322" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21683322</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.le_goff.2008.1119">Le Goff C, Morice-Picard F, Dagoneau N, Perrot C, Crow YJ, Bauer F, Flori E, Prost-Squarcioni C, Krakow D, Bonnet D, Le Merrer M, Apte SS, Munnich A, Cormier-Daire V. ADAMTSL2 mutations in geleophysic dysplasia reveal the role of ADAMTS-like proteins in regulation of TGF&#x003b2; bioavailability. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>:1119–23.</span> [<a href="/pmc/articles/PMC2675613/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2675613</span></a>] [<a href="/pubmed/18677313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18677313</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.lee.2013.456">Lee T, Takeshima Y, Okizuka Y, Hamahira K, Kusunoki N, Awano H, Yagi M, Sakai N, Matsuo M, Iijima K. A Japanese child with geleophysic dysplasia caused by a novel mutation of FBN1. <span><span class="ref-journal">Gene. </span>2013;<span class="ref-vol">512</span>:456–9.</span> [<a href="/pubmed/23124041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23124041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.li.2017.685">Li D, Dong H, Zheng H, Song J, Li X, Jin Y, Liu Y, Yang Y. A Chinese boy with geleophysic dysplasia caused by compound heterozygous mutations in ADAMTSL2. <span><span class="ref-journal">Eur J Med Genet. </span>2017;<span class="ref-vol">60</span>:685–9.</span> [<a href="/pubmed/28917829" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28917829</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.lipson.1991.824">Lipson A, Kan A, Kozlowski K. Geleophysic dysplasia: a further case. <span><span class="ref-journal">J Pediatr. </span>1991;<span class="ref-vol">118</span>:824–5.</span> [<a href="/pubmed/2019943" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2019943</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.lipson.1987.181">Lipson AH, Kan AE, Kozlowski K. Geleophysic dysplasia--acromicric dysplasia with evidence of glycoprotein storage. <span><span class="ref-journal">Am J Med Genet Suppl. </span>1987;<span class="ref-vol">3</span>:181–9.</span> [<a href="/pubmed/3130853" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3130853</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.mackenroth.2016.106">Mackenroth L, Rump A, Lorenz P, Schr&#x000f6;ck E, Tzschach A. Novel ADAMTSL2-mutations in a patient with geleophysic dysplasia type I. <span><span class="ref-journal">Clin Dysmorphol. </span>2016;<span class="ref-vol">25</span>:106–9.</span> [<a href="/pubmed/27057656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27057656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.matsui.2002.371">Matsui Y, Kawabata H, Yasui N. Multiple trigger fingers associated with geleophysic dysplasia. <span><span class="ref-journal">Arch Orthop Trauma Surg. </span>2002;<span class="ref-vol">122</span>:371–2.</span> [<a href="/pubmed/12136306" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12136306</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.mcinerneyleo.2016.457">McInerney-Leo AM, Le Goff C, Leo PJ, Kenna TJ, Keith P, Harris JE, Steer R, Bole-Feysot C, Nitschke P, Kielty C, Brown MA, Zankl A, Duncan EL, Cormier-Daire V. Mutations in LTBP3 cause acromicric dysplasia and geleophysic dysplasia. <span><span class="ref-journal">J Med Genet. </span>2016;<span class="ref-vol">53</span>:457–64.</span> [<a href="/pubmed/27068007" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27068007</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.noor.2009.519">Noor A, Windpassinger C, Vitcu I, Orlic M, Rafiq MA, Khalid M, Malik MN, Ayub M, Alman B, Vincent JB. Oligodontia is caused by mutation in LTBP3, the gene encoding latent TGF-beta binding protein 3. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">84</span>:519–23.</span> [<a href="/pmc/articles/PMC2667979/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2667979</span></a>] [<a href="/pubmed/19344874" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19344874</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.panagopoulos.2005.818">Panagopoulos P, Fryssira H, Koutras I, Daskalakis G, Economou A, Benetou V, Antsaklis A. Geleophysic dysplasia: a patient with a severe form of the disorder. <span><span class="ref-journal">J Obstet Gynaecol. </span>2005;<span class="ref-vol">25</span>:818–20.</span> [<a href="/pubmed/16368598" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16368598</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.peters.1985.225">Peters ME, Arya S, Langer LO, Gilbert EF, Carlson R, Adkins W. Narrow trachea in mucopolysaccharidoses. <span><span class="ref-journal">Pediatr Radiol. </span>1985;<span class="ref-vol">15</span>:225–8.</span> [<a href="/pubmed/3923421" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3923421</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.pontz.1996.50">Pontz BF, St&#x000f6;ss H, Henschke F, Freisinger P, Karbowski A, Spranger J. Clinical and ultrastructural findings in three patients with geleophysic dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">63</span>:50–4.</span> [<a href="/pubmed/8723086" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8723086</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.porayette.2014.209">Porayette P, Fruitman D, Lauzon JL, Le Goff C, Cormier-Daire V, Sanders SP, Pinto-Rojas A, Perez-Atayde AR. Novel mutations in geleophysic dysplasia type 1. <span><span class="ref-journal">Pediatr Dev Pathol. </span>2014;<span class="ref-vol">17</span>:209–16.</span> [<a href="/pubmed/24251637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24251637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR. UK10K Consortium, Hurles ME. Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.rennie.1997.1067">Rennie AC, Stewart G, Whiteford M, Johnston T, Tolmie JL. Expect the worse or hope for the best? Prenatal diagnosis of geleophysic dysplasia. <span><span class="ref-journal">Prenat Diagn. </span>1997;<span class="ref-vol">17</span>:1067–70.</span> [<a href="/pubmed/9399356" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9399356</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.rosser.1995.217">Rosser EM, Wilkinson AR, Hurst JA, McGaughran JM, Donnai D. Geleophysic dysplasia: a report of three affected boys--prenatal ultrasound does not detect recurrence. <span><span class="ref-journal">Am J Med Genet. </span>1995;<span class="ref-vol">58</span>:217–21.</span> [<a href="/pubmed/8533820" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8533820</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.santolaya.1997.85">Santolaya JM, Groninga LC, Delgado A, Monasterio JL, Camarero C, Bilbao FJ. Patients with geleophysic dysplasia are not always geleophysic. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">72</span>:85–90.</span> [<a href="/pubmed/9295082" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9295082</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.saricaoglu.2013.122">Saricaoglu MS, G&#x000fc;ven D, Karakurt A, Hasiripi H. Geleophysic dysplasia associated with bilateral angle closure glaucoma. <span><span class="ref-journal">Indian J Ophthalmol. </span>2013;<span class="ref-vol">61</span>:122–4.</span> [<a href="/pmc/articles/PMC3665041/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3665041</span></a>] [<a href="/pubmed/23514648" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23514648</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.scott.2005.320">Scott A, Yeung S, Dickinson DF, Karbani G, Crow YJ. Natural history of cardiac involvement in geleophysic dysplasia. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">132A</span>:320–3.</span> [<a href="/pubmed/15690380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15690380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.shohat.1990.227">Shohat M, Gruber HE, Pagon RA, Witcoff LJ, Lachman R, Ferry D, Flaum E, Rimoin DL. Geleophysic dysplasia: a storage disorder affecting the skin, bone, liver, heart, and trachea. <span><span class="ref-journal">J Pediatr. </span>1990;<span class="ref-vol">117</span>:227–32.</span> [<a href="/pubmed/2380821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2380821</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.spranger.1984a.487">Spranger J, Gilbert EF, Arya S, Hoganson GM, Opitz JM. Geleophysic dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>1984a;<span class="ref-vol">19</span>:487–99.</span> [<a href="/pubmed/6507495" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6507495</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.spranger.1984b.501">Spranger J, Gilbert EF, Flatz S, Burdelski M, Kallfelz HC. Acrofacial dysplasia resembling geleophysic dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>1984b;<span class="ref-vol">19</span>:501–6.</span> [<a href="/pubmed/6507496" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6507496</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.spranger.1971.97">Spranger JW, Gilbert EF, Tuffli GA, Rossiter FP, Opitz JM. Geleophysic dwarfism--a "focal" mucopolysaccharidosis? <span><span class="ref-journal">Lancet. </span>1971;<span class="ref-vol">2</span>:97–8.</span> [<a href="/pubmed/4104008" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4104008</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.titomanlio.1999.82">Titomanlio L, Della Casa R, Lecora M, Farina V, Sebastio G, Andria G, Parenti G. Geleophysic dysplasia: 7-year follow-up study of a patient with an intermediate form. <span><span class="ref-journal">Am J Med Genet. </span>1999;<span class="ref-vol">86</span>:82–5.</span> [<a href="/pubmed/10440835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10440835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.vanace.1960.80">Vanace PW, Friedman S, Wagner BM. Mitral stenosis in an atypical case of gargoylism: a case report with pathologic and histochemical studies of the cardiac tissues. <span><span class="ref-journal">Circulation. </span>1960;<span class="ref-vol">21</span>:80–9.</span> [<a href="/pubmed/13841169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 13841169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.wraith.1990.153">Wraith JE, Bankier A, Chow CW, Danks DM, Sardharwalla IB. Geleophysic dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>1990;<span class="ref-vol">35</span>:153–6.</span> [<a href="/pubmed/2090119" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2090119</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.zhang.2004.198">Zhang X, Boles RG, Law SK, Lin M. Ocular findings in geleophysic dysplasia. <span><span class="ref-journal">J AAPOS. </span>2004;<span class="ref-vol">8</span>:198–200.</span> [<a href="/pubmed/15088061" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15088061</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="geleophys-dysp.REF.zilberberg.2012.3828">Zilberberg L, Todorovic V, Dabovic B, Horiguchi M, Courouss&#x000e9; T, Sakai LY, Rifkin DB. Specificity of latent TGF-&#x003b2; binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin. <span><span class="ref-journal">J Cell Physiol. </span>2012;<span class="ref-vol">227</span>:3828–36.</span> [<a href="/pmc/articles/PMC3404192/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3404192</span></a>] [<a href="/pubmed/22495824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22495824</span></a>]</div></li></ul></div></div><div id="geleophys-dysp.Chapter_Notes"><h2 id="_geleophys-dysp_Chapter_Notes_">Chapter Notes</h2><div id="geleophys-dysp.Author_History"><h3>Author History</h3><p>Val&#x000e9;rie Cormier-Daire, MD, PhD (2009-present)<br />Carine Le Goff, PhD; Universit&#x000e9; Paris Descartes (2009-2018)<br />Pauline Marzin, MD (2018-present)</p></div><div id="geleophys-dysp.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 October 2018 (bp) Comprehensive update posted live</div></li><li class="half_rhythm"><div>19 April 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 September 2009 (et) Review posted live</div></li><li class="half_rhythm"><div>5 June 2009 (vcd) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK11168</span><span class="label">PMID: <a href="/pubmed/20301776" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301776</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/gaucher/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/gaci/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK11168&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK11168/?report=reader">PubReader</a></li><li><a href="/books/NBK11168/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK11168" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK11168" style="display:none" title="Cite this Page"><div class="bk_tt">Marzin P, Cormier-Daire V. Geleophysic Dysplasia. 2009 Sep 22 [Updated 2018 Oct 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK11168/pdf/Bookshelf_NBK11168.pdf">PDF version of this page</a> (461K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#geleophys-dysp.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#geleophys-dysp.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#geleophys-dysp.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#geleophys-dysp.Genetically_Related_Allel" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#geleophys-dysp.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#geleophys-dysp.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#geleophys-dysp.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#geleophys-dysp.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#geleophys-dysp.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#geleophys-dysp.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#geleophys-dysp.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=9719[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ADAMTSL2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2200[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FBN1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4054[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">LTBP3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK11168+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1617244" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1617244" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1617244" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1617244" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28406602" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Myhre Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Myhre Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Starr LJ, Lindor NM, Lin AE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22791552" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> From tall to short: the role of TGFβ signaling in growth and its disorders.</a><span class="source">[Am J Med Genet C Semin Med Gen...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> From tall to short: the role of TGFβ signaling in growth and its disorders.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Le Goff C, Cormier-Daire V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Med Genet C Semin Med Genet. 2012 Aug 15; 160C(3):145-53. Epub 2012 Jul 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301468" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Muscular Dystrophy Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sparks SE, Quijano-Roy S, Harper A, Rutkowski A, Gordon E, Hoffman EP, Pegoraro E. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301293" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Weill-Marchesani Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Weill-Marchesani Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tsilou E, MacDonald IM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301776" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301776" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040ee6dd21425a25734f38">Geleophysic Dysplasia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Geleophysic Dysplasia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:37:43-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89A1F1E04026810000000005D60269&amp;ncbi_session=CE89A1F1E040EE61_1494SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK11168%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK11168&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK11168/&amp;ncbi_pagename=Geleophysic Dysplasia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89A1F1E040EE61_1494SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>